Want news about Aurobindo Pharma to land in your mailbox?
Aurobindo drug gets US nod
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) for Lamotrigine tablets.
The tablets are generic equivalent to Lamictal of GlaxoSmithKline and fall under central nervous system segment.
They are indicated as adjunctive therapy for partial seizures and generalised seizures of Lennox-Gastaut syndrome in patients aged two years and older and for conversion to monotherapy in adults with partial seizures.
|
|
The product would be launched soon, the Hyderabad-based company said in a release.
Taken from Business Line
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
Harsh Manglik
Harsh Manglik
Chairman
Accenture India
Accenture India to hire aggressively for select verticals
Vishal Doshi
Vishal Doshi
Managing Director
Shrenju & Company
Shrenuj & Company will project 15% rev rise this yr
MP Taparia
MP Taparia
Chairman
Supreme Petrochemicals
Supreme Petrochemicals expects Rs 2200cr rev in next 1.5yrs
Vineet Nayyar
Vineet Nayyar
Chief Executive Officer
HCL Technologies
HCL Tech plans to merge arms with itself, eyes new spots
-
Most Read
-
Most Viewed
- UBS Sec: Good level to enter mkts, suggests stocks
- Mitesh Thacker's top 5 picks for today's trade
- Nifty to cross 5100; infra, banking best bets: Quantum Sec
- End of BPLR: RBI to de-regulate lending rates in FY11
- ARSS Infrastructure IPO opens; should you subscribe?
- Jubilant Food's anchor investors buy add'l stake on debut
- SAIL to issue bonus shares before FPO: Sources
- Ten success stories in unheard of sectors
- What is Religare Capital betting on in the long-term?
- India a stock picker's market: JPMorgan Sec
- China confirmed as global export champion
Source: ft.com
- Time to understand how the mighty fall
Source: ft.com
- India growth set to near 2007 boom levels
Source: ft.com
- Speculators build record bets against euro
Source: ft.com
